Zenni Pharmaceutical Private Limited
Metformin (500mg) + Linagliptin (2.5mg)
Xamfloglip 500mg/2.5mg Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus.
Tablet
Xamfloglip 500mg/2.5mg Tablet is a combination of two medicines that control high blood sugar levels in people with type 2 diabetes mellitus. This helps prevent serious complications of diabetes such as kidney damage and blindness and may reduce your chance of having a heart attack or stroke.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Xamfloglip 500mg/2.5mg Tablet is to be taken with food.
No common side effects listed.
It is unsafe to consume alcohol with Xamfloglip 500mg/2.5mg Tablet.
Xamfloglip 500mg/2.5mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Xamfloglip 500mg/2.5mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Xamfloglip 500mg/2.5mg Tablet is a combination of two antidiabetic medicines:
Xamfloglip 500mg/2.5mg Tablet should be taken with food to lower the chances of having an upset stomach. Take it in addition to regular exercise and a healthy diet to lower the levels of blood sugar. Chances of weight gain and low blood sugar are lesser as compared to other diabetes medicines. Hypoglycemia (low blood sugar level) may occur when taken along with other antidiabetic medicines, alcohol or on delaying/skipping a meal. Carry a sugar source with you for immediate relief. Monitor your blood sugar level regularly while you are taking this medicine. Inform your doctor about your diabetes treatment if you are due to have any surgery under a general anaesthetic. Tell your doctor immediately if you experience any deep or rapid breathing, persistent nausea, vomiting or stomach pain as Xamfloglip 500mg/2.5mg Tablet may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
Yes, the use of Xamfloglip 500mg/2.5mg Tablet can lead to a rare side effect known as lactic acidosis, also referred to as MALA (Metformin-associated lactic acidosis). This is caused by increased levels of lactic acid in the blood. Symptoms may include muscle pain or weakness, dizziness, tiredness, feeling cold in arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or slow heart rate. If you experience these symptoms, stop taking Xamfloglip 500mg/2.5mg Tablet and consult your doctor immediately.
The use of Xamfloglip 500mg/2.5mg Tablet may cause common side effects like low blood sugar level (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. It can also lead to a serious but rare side effect known as lactic acidosis. Additionally, long-term use of this medicine may interfere with the absorption of vitamin B12 in the stomach.
The use of Xamfloglip 500mg/2.5mg Tablet should be avoided in patients with known allergies to any component of this medicine, severe kidney impairment, liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
No, it is not recommended to consume alcohol while taking Xamfloglip 500mg/2.5mg Tablet, as this can increase the risk of lactic acidosis, especially in cases of fasting, malnutrition, or kidney dysfunction.
Keep Xamfloglip 500mg/2.5mg Tablet in its original packaging, tightly closed, and store it according to the instructions on the pack or label. Dispose of unused medicine properly.
Xamfloglip 500mg/2.5mg Tablet itself does not usually cause low blood sugar levels (hypoglycemia). However, it may occur if there is insufficient calorie supplementation while taking this medicine.
Yes, long-term use of Xamfloglip 500mg/2.5mg Tablet may cause a decrease in the absorption of vitamin B12 in the stomach, potentially leading to anemia and nerve problems.